April 4th, 2019 – Important new safety information (PDF - 60.4 KB) regarding BENLYSTA (belimumab)
April 25th, 2014 – Important new safety information (PDF - 251 KB) regarding BENLYSTA (belimumab)
May 3, 2012- Important safety information (PDF - 205 KB) regarding the association of BENLYSTA (belimumab) with hypersensitivity and infusion reactions.
Patient information:
April 25th, 2014 – Important new safety information (PDF - 252 KB) for patients currently receiving BENLYSTA (belimumab)
May 8, 2012 – Important information (PDF - 216 KB) for patients regarding the association of BENLYSTA (belimumab) with hypersensitivity and infusion reactions.
You are leaving our website
The information you are about to be referred to may not comply with the local regulatory requirements. Further information relevant to the local environment is available from the company or via the Product Information.
